Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 16

1.

Outcomes and diffusion of doxorubicin-based chemotherapy among elderly patients with aggressive non-Hodgkin lymphoma.

Grann VR, Hershman D, Jacobson JS, Tsai WY, Wang J, McBride R, Mitra N, Grossbard ML, Neugut AI.

Cancer. 2006 Oct 1;107(7):1530-41.

PMID:
16933332
[PubMed - indexed for MEDLINE]
Free Article
2.

Rituximab-CHOP versus CHOP alone or with maintenance rituximab in older patients with diffuse large B-cell lymphoma.

Habermann TM, Weller EA, Morrison VA, Gascoyne RD, Cassileth PA, Cohn JB, Dakhil SR, Woda B, Fisher RI, Peterson BA, Horning SJ.

J Clin Oncol. 2006 Jul 1;24(19):3121-7. Epub 2006 Jun 5.

PMID:
16754935
[PubMed - indexed for MEDLINE]
Free Article
3.

Cost-effectiveness analysis of rituximab combined with chop for treatment of diffuse large B-cell lymphoma.

Best JH, Hornberger J, Proctor SJ, Omnes LF, Jost F.

Value Health. 2005 Jul-Aug;8(4):462-70.

PMID:
16091023
[PubMed - indexed for MEDLINE]
4.

Introduction of combined CHOP plus rituximab therapy dramatically improved outcome of diffuse large B-cell lymphoma in British Columbia.

Sehn LH, Donaldson J, Chhanabhai M, Fitzgerald C, Gill K, Klasa R, MacPherson N, O'Reilly S, Spinelli JJ, Sutherland J, Wilson KS, Gascoyne RD, Connors JM.

J Clin Oncol. 2005 Aug 1;23(22):5027-33. Epub 2005 Jun 13.

PMID:
15955905
[PubMed - indexed for MEDLINE]
Free Article
5.

Long-term results of the R-CHOP study in the treatment of elderly patients with diffuse large B-cell lymphoma: a study by the Groupe d'Etude des Lymphomes de l'Adulte.

Feugier P, Van Hoof A, Sebban C, Solal-Celigny P, Bouabdallah R, Fermé C, Christian B, Lepage E, Tilly H, Morschhauser F, Gaulard P, Salles G, Bosly A, Gisselbrecht C, Reyes F, Coiffier B.

J Clin Oncol. 2005 Jun 20;23(18):4117-26. Epub 2005 May 2.

PMID:
15867204
[PubMed - indexed for MEDLINE]
Free Article
7.

Cost-effectiveness of rituximab (MabThera) in diffuse large B-cell lymphoma in The Netherlands.

Groot MT, Lugtenburg PJ, Hornberger J, Huijgens PC, Uyl-de Groot CA.

Eur J Haematol. 2005 Mar;74(3):194-202.

PMID:
15693788
[PubMed - indexed for MEDLINE]
8.

Utility of the SEER-Medicare data to identify chemotherapy use.

Warren JL, Harlan LC, Fahey A, Virnig BA, Freeman JL, Klabunde CN, Cooper GS, Knopf KB.

Med Care. 2002 Aug;40(8 Suppl):IV-55-61.

PMID:
12187169
[PubMed - indexed for MEDLINE]
9.

CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.

Coiffier B, Lepage E, Briere J, Herbrecht R, Tilly H, Bouabdallah R, Morel P, Van Den Neste E, Salles G, Gaulard P, Reyes F, Lederlin P, Gisselbrecht C.

N Engl J Med. 2002 Jan 24;346(4):235-42.

PMID:
11807147
[PubMed - indexed for MEDLINE]
Free Article
10.

Phase II study of rituximab in combination with chop chemotherapy in patients with previously untreated, aggressive non-Hodgkin's lymphoma.

Vose JM, Link BK, Grossbard ML, Czuczman M, Grillo-Lopez A, Gilman P, Lowe A, Kunkel LA, Fisher RI.

J Clin Oncol. 2001 Jan 15;19(2):389-97.

PMID:
11208830
[PubMed - indexed for MEDLINE]
11.

Development of a comorbidity index using physician claims data.

Klabunde CN, Potosky AL, Legler JM, Warren JL.

J Clin Epidemiol. 2000 Dec;53(12):1258-67.

PMID:
11146273
[PubMed - indexed for MEDLINE]
12.

Rituximab (anti-CD20 monoclonal antibody) for the treatment of patients with relapsing or refractory aggressive lymphoma: a multicenter phase II study.

Coiffier B, Haioun C, Ketterer N, Engert A, Tilly H, Ma D, Johnson P, Lister A, Feuring-Buske M, Radford JA, Capdeville R, Diehl V, Reyes F.

Blood. 1998 Sep 15;92(6):1927-32.

PMID:
9731049
[PubMed - indexed for MEDLINE]
Free Article
13.

Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a four-dose treatment program.

McLaughlin P, Grillo-López AJ, Link BK, Levy R, Czuczman MS, Williams ME, Heyman MR, Bence-Bruckler I, White CA, Cabanillas F, Jain V, Ho AD, Lister J, Wey K, Shen D, Dallaire BK.

J Clin Oncol. 1998 Aug;16(8):2825-33.

PMID:
9704735
[PubMed - indexed for MEDLINE]
14.

Potential for cancer related health services research using a linked Medicare-tumor registry database.

Potosky AL, Riley GF, Lubitz JD, Mentnech RM, Kessler LG.

Med Care. 1993 Aug;31(8):732-48.

PMID:
8336512
[PubMed - indexed for MEDLINE]
15.

Comparison of doxorubicin and mitoxantrone in the treatment of elderly patients with advanced diffuse non-Hodgkin's lymphoma using CHOP versus CNOP chemotherapy.

Sonneveld P, de Ridder M, van der Lelie H, Nieuwenhuis K, Schouten H, Mulder A, van Reijswoud I, Hop W, Lowenberg B.

J Clin Oncol. 1995 Oct;13(10):2530-9.

PMID:
7595704
[PubMed - indexed for MEDLINE]
16.

A new method of classifying prognostic comorbidity in longitudinal studies: development and validation.

Charlson ME, Pompei P, Ales KL, MacKenzie CR.

J Chronic Dis. 1987;40(5):373-83.

PMID:
3558716
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk